Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sanders, M.
Right arrow Articles by Rogers, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sanders, M.
Right arrow Articles by Rogers, R.

Chest, Vol 90, 330-333, Copyright © 1986 by American College of Chest Physicians


ARTICLES

Patient compliance with nasal CPAP therapy for sleep apnea

MH Sanders, CA Gruendl and RM Rogers

Continuous positive airway pressure via the nasal route (nasal CPAP) is effective in reducing the frequency of occlusive and mixed patterns of sleep apnea. Little is known about long-term patient compliance with this therapeutic modality, however. In order to evaluate this, questionnaires were mailed to 24 sleep apnea patients who had received a nasal CPAP system for nightly use. Patients were requested not to sign the questionnaire. At the time of mailing, the patients had possessed their nasal CPAP equipment for 10.3 +/- 8 months (mean +/- SD). Twenty patients (83 percent) responded to the questionnaire. Sixteen responders used nasal CPAP during all nightly sleep time, and two used it for all but one and 2.5 hours of nightly sleep time, respectively. One individual used it on alternate nights, and one patient did not use it all. Thus, 17 of 20 (85 percent) responders were compliant. Including information about the four nonresponders, obtained by means other than questionnaire, 18 of 24 (75 percent) patients were compliant with therapy. All but two patients were obese at the time sleep apnea was diagnosed. Only 50 percent of questionnaire responders reported weight loss after receiving nasal CPAP, and these individuals were frequent nasal CPAP users. The most common complaints were mask discomfort (14 responders) and nasal dryness and congestion (13 responders). We conclude that long-term home nasal CPAP is a viable therapy that is conscientiously applied and well-tolerated by most sleep apnea patients.


This article has been cited by other articles:


Home page
Clinical Case StudiesHome page
C. S. McCrae and P. T. Ingmundson
Using Graduated in Vivo Exposure to Treat a Claustrophobic Response to Nasal Continuous Positive Airway Pressure: Hispanic Male Veteran Associates Nasal Mask With Gas Masks Worn During Combat
Clinical Case Studies, February 1, 2006; 5(1): 71 - 82.
[Abstract] [PDF]


Home page
Eur Respir JHome page
M. Duong, L. Jayaram, D. Camfferman, P. Catcheside, I. Mykytyn, and R. D. McEvoy
Use of heated humidification during nasal CPAP titration in obstructive sleep apnoea syndrome
Eur. Respir. J., October 1, 2005; 26(4): 679 - 685.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. A. Massie and R. W. Hart
Clinical Outcomes Related to Interface Type in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome Who Are Using Continuous Positive Airway Pressure
Chest, April 1, 2003; 123(4): 1112 - 1118.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
B.M. Sanner, M. Heise, B. Knoben, M. Machnick, U. Laufer, R. Kikuth, W. Zidek, and B. Hellmich
MRI of the pharynx and treatment efficacy of a mandibular advancement device in obstructive sleep apnoea syndrome
Eur. Respir. J., July 1, 2002; 20(1): 143 - 150.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. Rakotonanahary, N. Pelletier-Fleury, F. Gagnadoux, and B. Fleury
Predictive Factors for the Need for Additional Humidification During Nasal Continuous Positive Airway Pressure Therapy
Chest, February 1, 2001; 119(2): 460 - 465.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. T. Martins de Araujo, S. B. Vieira, E. C. Vasquez, and B. Fleury
Heated Humidification or Face Mask To Prevent Upper Airway Dryness During Continuous Positive Airway Pressure Therapy*
Chest, January 1, 2000; 117(1): 142 - 147.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. A. Massie, R. W. Hart, K. Peralez, and G. N. Richards
Effects of Humidification on Nasal Symptoms and Compliance in Sleep Apnea Patients Using Continuous Positive Airway Pressure
Chest, August 1, 1999; 116(2): 403 - 408.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
N. MCARDLE, G. DEVEREUX, H. HEIDARNEJAD, H. M. ENGLEMAN, T. W. MACKAY, and N. J. DOUGLAS
Long-term Use of CPAP Therapy for Sleep Apnea/Hypopnea Syndrome
Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): 1108 - 1114.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J H Ficker, G H Wiest, G Lehnert, B Wiest, and E G Hahn
Evaluation of an auto-CPAP device for treatment of obstructive sleep apnoea
Thorax, August 1, 1998; 53(8): 643 - 648.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American College of Chest Physicians.